| Doxazosin Mesylate Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Doxazosin Mesylate 1 mg | tablet | oral | 1.0 each | OTC |
| Doxazosin Mesylate 8 mg | tablet | oral | 1.0 each | OTC |
| Doxazosin Mesylate 2 mg | tablet | oral | 1.0 each | OTC |
| Doxazosin Mesylate 4 mg | tablet | oral | 1.0 each | OTC |
Patients With Metabolic Disorder Show Comparable Or Better Results ... - Medical News Today
... a calcium channel blocker (amlodipine besylate, 9048 patients), an alpha-blocker (doxazosin mesylate, 9061 patients) or an ACE inhibitor (lisinopril, ...
Sat Feb 02 03:01:46 -0500 2008
Diuretics Most Effective Blood Pressure Medication for People with ... - Media Newswire (press release)
... blocker ( amlodipine besylate ), an alpha-blocker ( doxazosin mesylate ), and an angiotensin-converting enzyme ( ACE ) inhibitor ( lisinopril ). ...
Tue Jan 29 12:14:20 -0500 2008
Evidence strongly supports diuretics as initial metabolic syndrome ... - News-Medical.net
... calcium-channel blocker (amlodipine besylate), an alpha-blocker (doxazosin mesylate), and an angiotensin-converting enzyme (ACE) inhibitor (lisinopril). ...
Mon Jan 28 18:31:01 -0500 2008
doxazosin mesylate - The mesylate salt form of doxazosin, a quinazoline compound with smooth muscle relaxing activity. Doxazosin mesylate selectively antagonizes alpha1-adrenergic receptors in smooth muscle of the bladder neck and prostate, thereby relaxing the smooth muscle and decreasing the obstruction and urethral resistance seen with benign prostate hyperplasia (BPH). This may improve BPH symptoms. This agent also blocks alpha1-adrenergic receptors in peripheral vascular smooth muscle, which leads to vasodilatation and a subsequent decrease in peripheral vascular resistance.